BRIEF-Alexion receives positive CHMP opinion for Soliris in the EU
* Alexion receives positive CHMP opinion for Soliris (eculizumab) for the treatment of patients with refractory Generalized Myasthenia Gravis (GMG) in the European Union
SAO PAULO May 18 Brazil's JBS SA, the world's largest meatpacker, said on Thursday that seven of its executives and its parent company J&F Investimentos had signed plea agreements with prosecutors regarding the country's widest-ever corruption probe.
In a securities filing on Thursday, JBS said the executives will pay a 225 million reais ($67 million) fine.
($1 = 3.3685 reais) (Reporting by Tatiana Bautzer; Editing by Christian Plumb and Sandra Maler)
* Ultragenyx pharmaceutical inc - based on agreement, submission of burosumab bla is planned for second half of 2017
* Perficient Inc - acquisition is expected to be accretive to adjusted earnings per share immediately